Vor Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
Vor Bio (NASDAQ:VOR), a clinical-stage biotech company focused on autoimmune disease treatments, has announced its participation in the upcoming Stifel 2025 Virtual Immunology and Inflammation Forum. The company will engage in a fireside chat on Monday, September 15, 2025, from 4:00-4:25 pm ET in Track 1.
The virtual event will also include one-on-one meetings with investors. Both live webcast and replay of the fireside chat will be accessible through Vor Bio's investor relations website.
Vor Bio (NASDAQ:VOR), azienda biotech in fase clinica focalizzata sui trattamenti per malattie autoimmuni, ha annunciato la sua partecipazione al prossimo Stifel 2025 Virtual Immunology and Inflammation Forum. L'azienda parteciperà a una fireside chat lunedì 15 settembre 2025, dalle 16:00 alle 16:25 ET nella Track 1. L'evento virtuale includerà anche incontri one-to-one con gli investitori. Sia la trasmissione in diretta che la replica della fireside chat saranno accessibili sul sito di relazioni investitori di Vor Bio.
Vor Bio (NASDAQ:VOR), una empresa biofarmacéutica en etapa clínica centrada en tratamientos para enfermedades autoinmunes, ha anunciado su participación en el próximo Stifel 2025 Virtual Immunology and Inflammation Forum. La compañía participará en una conversación informal (fireside chat) el lunes 15 de septiembre de 2025, de 16:00 a 16:25 ET en la Track 1. El evento virtual también incluirá reuniones individuales con inversionistas. Tanto la transmisión en vivo como la repetición de la fireside chat estarán accesibles a través del sitio web de relaciones con inversionistas de Vor Bio.
Vor Bio (NASDAQ:VOR), 면역 질환 치료에 초점을 맞춘 임상 단계 생명공학 회사가 다가오는 Stifel 2025 Virtual Immunology and Inflammation Forum 참여를 발표했습니다. 이 회사는 2025년 9월 15일 월요일 오후 4:00~4:25 ET의 Track 1에서 fireside chat에 참여할 예정입니다. 가상 이벤트에는 투자자와의 일대일 미팅도 포함됩니다. 라이브 생중계와 fireside chat의 재생은 Vor Bio의 투자자 관계 웹사이트를 통해 접근할 수 있습니다.
Vor Bio (NASDAQ:VOR), une société biotechnologique en phase clinique axée sur les traitements des maladies auto-immunes, a annoncé sa participation au prochain Stifel 2025 Virtual Immunology and Inflammation Forum. L'entreprise interviendra lors d'une fireside chat le lundi 15 septembre 2025, de 16 h 00 à 16 h 25 HE sur la Track 1. L'événement virtuel comprendra également des rendez-vous individuels avec des investisseurs. Tant la diffusion en direct que la réplique de la fireside chat seront accessibles via le site des relations investisseurs de Vor Bio.
Vor Bio (NASDAQ:VOR), ein klinisch orientiertes Biotech-Unternehmen, das sich auf Behandlungen von Autoimmunerkrankungen konzentriert, hat seine Teilnahme am bevorstehenden Stifel 2025 Virtual Immunology and Inflammation Forum angekündigt. Das Unternehmen wird am Montag, den 15. September 2025, von 16:00 bis 16:25 Uhr ET in Track 1 an einer Fireside Chat teilnehmen. Die virtuelle Veranstaltung wird auch Einzelgespräche mit Investoren beinhalten. Sowohl die Live-Übertragung als auch die Wiederholung der Fireside Chat werden über die Investor-Relations-Website von Vor Bio zugänglich sein.
فيور بايو (NASDAQ:VOR)، شركة أبحاث بيولوجية حيوية في مرحلة التجارب السريرية ومختصة بعلاجات الأمراض المناعية الذاتية، أعلنت عن مشاركتها في المنتدى الافتراضي القادم للصحة المناعية والالتهابات من ستيفل 2025. ستشارك الشركة في جلسة fireside chat يوم الاثنين 15 سبتمبر 2025، من الساعة 4:00 إلى 4:25 مساءً بتوقيت شرق الولايات المتحدة في المسار 1. كما سيشمل الحدث الافتراضي لقاءات فردية مع المستثمرين. يمكن الوصول إلى البث المباشر وإعادة جلسة fireside chat من خلال موقع علاقات المستثمرين الخاص بـ Vor Bio.
Vor Bio (NASDAQ:VOR)，一家专注于自身免疫疾病治疗的临床阶段生物科技公司，已宣布将参加即将举行的 Stifel 2025 Virtual Immunology and Inflammation Forum。该公司将于2025年9月15日（星期一）美东时间16:00–16:25，在 Track 1 参与一场炉边对谈（fireside chat）。该虚拟活动还将包括与投资者的一对一会议。直播和炉边对谈的重播都可通过 Vor Bio 的投资者关系网站访问。
- None.
- None.
CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the Stifel 2025 Virtual Immunology and Inflammation Forum.
Fireside Chat: Monday, September 15, 2025 at 4:00-4:25 pm ET in Track 1
Location: Virtual
A live webcast and archived replay of the fireside chat will be available on the Company’s website at: https://ir.vorbio.com/events-presentations/
About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com.
Media & Investor Contacts:
Carl Mauch
cmauch@vorbio.com
Sarah Spencer
investors@vorbio.com
FAQ
When is Vor Bio's fireside chat at the Stifel 2025 Virtual Immunology Forum?
How can investors access Vor Bio's Stifel 2025 Forum presentation?
What type of meetings will Vor Bio host at the Stifel 2025 Forum?
What is Vor Bio's focus as a clinical-stage biotech company?
